These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial. Bril V; Hadden RDM; Brannagan TH; Bar M; Chroni E; Rejdak K; Rivero A; Andersen H; Latov N; Levine T; Pasnoor M; Sacconi S; Souayah N; Anderson-Smits C; Duff K; Greco E; Hasan S; Li Z; Yel L; Ay H J Peripher Nerv Syst; 2023 Sep; 28(3):436-449. PubMed ID: 37314318 [TBL] [Abstract][Full Text] [Related]
14. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. van Doorn PA; Brand A; Strengers PF; Meulstee J; Vermeulen M Neurology; 1990 Feb; 40(2):209-12. PubMed ID: 2405291 [TBL] [Abstract][Full Text] [Related]
15. Clinical and electrophysiological correlation in chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin therapy: a case report. Han NH; Huang CC; Tsai CP Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jan; 59(1):42-6. PubMed ID: 9134822 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Markvardsen LH; Debost JC; Harbo T; Sindrup SH; Andersen H; Christiansen I; Otto M; Olsen NK; Lassen LL; Jakobsen J; Eur J Neurol; 2013 May; 20(5):836-42. PubMed ID: 23294032 [TBL] [Abstract][Full Text] [Related]
17. A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. Cornblath DR; Hartung HP; Katzberg HD; Merkies ISJ; van Doorn PA J Peripher Nerv Syst; 2018 Jun; 23(2):108-114. PubMed ID: 29603842 [TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794 [TBL] [Abstract][Full Text] [Related]